Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antifungal agents.

Irene Lu1, Elizabeth Dodds, John Perfect

  • 1Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC 27710, USA.

Seminars in Respiratory Infections
|June 19, 2002
PubMed
Summary

Managing fungal infections is challenging due to complex patient illnesses and limited antifungal drugs. New strategies are needed for earlier diagnosis, targeted prophylaxis, and novel therapies to combat antifungal drug resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new species of <i>Xylopia</i> (Annonaceae) from the Amazon Basin, with a review of trunciflorous cauliflory in the genus.

PhytoKeys·2026
Same author

MUC16-dependent Renal Vascular Adhesion of Candida Promotes Tissue Invasion and Predicts Clinical Outcome in Candidemia.

Research square·2026
Same author

In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis.

PLoS neglected tropical diseases·2025
Same author

In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis.

bioRxiv : the preprint server for biology·2025
Same author

An endoscopic strategy for oesophageal food bolus impactions: a multicentre retrospective study of 750 patients over a decade.

Internal medicine journal·2025
Same author

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy.

Mycopathologia·2025

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Fungal infections pose a growing concern, particularly in patients with complex underlying conditions.
  • Limited antifungal agents and current preventative strategies contribute to challenges in treatment and the rise of resistant pathogens.
  • The emergence of drug-resistant fungal strains necessitates improved therapeutic approaches.

Purpose of the Study:

  • To highlight the increasing challenges in treating fungal infections.
  • To emphasize the need for improved diagnostic and prophylactic strategies.
  • To underscore the importance of developing novel antifungal agents and optimizing current treatments.

Main Methods:

  • Review of current treatment strategies for fungal infections.
  • Analysis of the impact of existing antifungal agents and preventative measures.
  • Discussion of emerging therapeutic options and resistance patterns.

Main Results:

  • Current preventative strategies may lead to resistant pathogens and superinfections.
  • New antifungal agents show promise but outcomes remain suboptimal for many severely ill patients.
  • Clinical antifungal drug resistance is a significant issue requiring improved therapeutic strategies.

Conclusions:

  • Earlier diagnosis and targeted prophylaxis are crucial to limit the use of toxic pharmaceuticals.
  • Development of new antifungal therapies and optimization of current agent administration are essential.
  • Combating clinical antifungal drug resistance requires a multifaceted improvement in therapeutic strategies.

Related Experiment Videos